Itoco Inc. (ITMC)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.86 Million USD | 47.47% |
| 2022 | -1.82 Million USD | -68.08% |
| 2021 | -37.99 Thousand USD | 18.83% |
| 2020 | -1.41 Million USD | 47.41% |
| 2019 | -2.97 Million USD | -6.81% |
| 2018 | -2.69 Million USD | -41.28% |
| 2017 | -1.73 Million USD | -218.31% |
| 2016 | -507.78 Thousand USD | -25.44% |
| 2015 | -393.79 Thousand USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2009 | -1.24 Million USD | -1860.41% |
| 2008 | 2.52 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 FY | - USD | 47.47% |
| 2023 Q3 | -239 Thousand USD | -2.64% |
| 2023 Q2 | -232.85 Thousand USD | 13.63% |
| 2023 Q4 | -177.69 Thousand USD | 25.65% |
| 2023 Q1 | -269.6 Thousand USD | 35.62% |
| 2022 FY | - USD | -68.08% |
| 2022 Q1 | -159.98 Thousand USD | -135.53% |
| 2022 Q4 | -418.77 Thousand USD | 47.43% |
| 2022 Q3 | -796.54 Thousand USD | -112.44% |
| 2022 Q2 | -374.95 Thousand USD | -134.37% |
| 2021 Q4 | 450.22 Thousand USD | 255.08% |
| 2021 FY | - USD | 18.83% |
| 2021 Q1 | -300.83 Thousand USD | 0.0% |
| 2021 Q2 | -251.67 Thousand USD | 16.34% |
| 2021 Q3 | -290.32 Thousand USD | -15.36% |
| 2020 FY | - USD | 47.41% |
| 2019 FY | - USD | -6.81% |
| 2018 FY | - USD | -41.28% |
| 2017 FY | - USD | -218.31% |
| 2016 FY | - USD | -25.44% |
| 2015 FY | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2010 Q3 | -112.04 Thousand USD | -53.82% |
| 2010 Q2 | -72.84 Thousand USD | 27.38% |
| 2010 Q1 | -100.29 Thousand USD | 91.69% |
| 2009 Q1 | -15.37 Thousand USD | -55.83% |
| 2009 Q3 | -6435.00 USD | 58.46% |
| 2009 Q4 | -1.2 Million USD | -18651.27% |
| 2009 Q2 | -15.49 Thousand USD | -0.77% |
| 2009 FY | - USD | -1860.41% |
| 2008 Q4 | -9865.00 USD | 1.67% |
| 2008 Q1 | -34.37 Thousand USD | 0.0% |
| 2008 Q3 | -10.03 Thousand USD | -10.02% |
| 2008 Q2 | -9119.00 USD | 73.47% |
| 2008 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 97.369% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 68.477% |
| SQZ Biotechnologies Company | -64.14 Million USD | 97.086% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 89.24% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 101.987% |
| Mesoblast Limited | -62.38 Million USD | 97.004% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -21.675% |
| Genus plc | 73.7 Million USD | 102.536% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 71.731% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 47.308% |
| Marizyme, Inc. | -34.28 Million USD | 94.548% |
| ContraFect Corporation | -64.99 Million USD | 97.125% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 78.694% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 58.707% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -33.327% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 29.324% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 19.572% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -260.778% |
| Accustem Sciences Inc. | -3.74 Million USD | 50.112% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 96.125% |
| EV Biologics, Inc. | -1.26 Million USD | -47.498% |
| Q BioMed Inc. | -617.62 Thousand USD | -202.609% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 152.323% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -195.537% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 18.188% |
| Biomind Labs Inc. | -1.03 Million USD | -80.658% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 118.923% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 73.901% |
| Skye Bioscience, Inc. | -13.54 Million USD | 86.204% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -25.654% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -7375.98% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 51.884% |
| IMV Inc. | -35.52 Million USD | 94.739% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 88.223% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 25.299% |
| GB Sciences, Inc. | -1.41 Million USD | -31.63% |
| Alpha Cognition Inc. | -9.7 Million USD | 80.743% |
| HST Global, Inc. | -5303.00 USD | -35144.107% |
| CSL Limited | 4.78 Billion USD | 100.039% |
| Halberd Corporation | -74.27 Thousand USD | -2416.182% |
| Enzolytics Inc. | -2.12 Million USD | 11.924% |
| Resverlogix Corp. | -11.74 Million USD | 84.083% |
| Affymax, Inc. | -14.29 Million USD | 86.926% |
| SYBLEU INC | -141.57 Thousand USD | -1220.182% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 38.982% |
| argenx SE | -216.02 Million USD | 99.135% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 96.623% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 253.574% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -24.691% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 593.342% |
| AVAX Technologies, Inc. | -6.11 Million USD | 69.424% |
| Zenith Capital Corp. | -8.6 Million USD | 78.283% |
| Genscript Biotech Corporation | -248.71 Million USD | 99.249% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -10628.403% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 23.604% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -961.782% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 95.285% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 35.381% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -78.627% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 27895.88% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -6.8% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | 2.703% |
| BioStem Technologies, Inc. | -7.55 Million USD | 75.257% |
| ONE Bio Corp. | 13.61 Million USD | 113.729% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -932.092% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | 9.14% |
| Agentix Corp. | -1.37 Million USD | -36.248% |
| LadRx Corporation | 412.28 Thousand USD | 553.328% |
| Cell Source, Inc. | -4.27 Million USD | 56.256% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -408.956% |
| Regen BioPharma, Inc. | 1.46 Million USD | 227.493% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -99.477% |
| NovAccess Global Inc. | -1.03 Million USD | -80.615% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 121.11% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -392.333% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -67.473% |
| Kadimastem Ltd | -2.62 Million USD | 28.783% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -681.516% |
| CytoDyn Inc. | -18.02 Million USD | 89.633% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -2264.948% |
| Mobile Lads Corp. | -2.24 Million USD | 16.606% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -15183.302% |
| Qrons Inc. | -40.08 Thousand USD | -4563.045% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -284.822% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 454.357% |
| Rebus Holdings, Inc. | -951 Thousand USD | -96.529% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -75.987% |
| International Stem Cell Corporation | 202 Thousand USD | 1025.245% |
| Bioxytran, Inc. | -3.82 Million USD | 51.075% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -3450.522% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 24.084% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 94.789% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -4053.322% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 31.739% |
| Neutra Corp. | -181.24 Thousand USD | -931.187% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 90.729% |
| PureTech Health plc | -11.62 Million USD | 83.925% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 90.728% |
| IXICO plc | -707 Thousand USD | -164.356% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 75.68% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 96.134% |
| CSL Limited | 4.73 Billion USD | 100.039% |
| Cellectis S.A. | -92.63 Million USD | 97.982% |